Statins are one of the most commonly prescribed medications to help reduce cholesterol and reduce the risk of cardiovascular events like heart attack and stroke. I’ve been asked the question a few different times about why we should choose a hydrophilic versus a...
Orthostasis risk with SGLT-2 Inhibitors is a potential minor concern, particularly in our geriatric population. While a drop in blood pressure can be a good thing for a significant chunk of diabetes patients, that potential modest drop can lead to an increased...
Patient adherence is not the sexiest topic on the planet, but you must understand how prevalent this problem is. You can be the smartest clinician on the planet and select the most appropriate medication for your patient every time, but does it really matter if they...
Apixaban (Eliquis) is a somewhat newer anticoagulant. While it is tempting to utilize the “set it and forget it” mindset with dosing, we must remember that there are a few reasons that we might have to make apixaban dose adjustments. Apixaban dose...
Today I’m going to discuss a case involving a patient concern with inappropriate production of milk (formally known as galactorrhea). Keep an eye at the end of this post for some MAJOR announcements about upcoming content releases! For now, here’s the...
Should we use cilostazol in heart failure? A 68 year old male smoker has a past medical history of peripheral vascular disease, cardiovascular disease, myocardial infarction X2, osteoarthritis, CHF and constipation. He has an extensive medication list that includes;...
